Published in CMAJ on October 31, 2000
Drug treatment of pulmonary hypertension in children. Paediatr Drugs (2014) 0.86
Current challenges in pediatric pulmonary hypertension. Semin Respir Crit Care Med (2013) 0.85
Erectile dysfunction among diabetic patients in saudi arabia: a hospital-based primary care study. J Family Community Med (2007) 0.81
Mechanism of endothelial cyto-protective and thrombo-resistance effects of sildenafil, vardenafil and tadalafil in male rabbit. Arch Med Sci (2013) 0.78
Hua Fo tablets tainted with sildenafil-like compound. CMAJ (2002) 0.75
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology (1997) 13.27
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med (1998) 12.67
ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol (1999) 2.37
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A (1994) 2.28
Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol (1999) 2.25
Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med (2000) 1.79
Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol (1998) 1.66
Potassium channel diversity in vascular smooth muscle cells. Can J Physiol Pharmacol (1997) 0.96
Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg (1996) 1.77
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res (1995) 1.49
Soil moisture redistribution as a mechanism of facilitation in savanna tree-shrub clusters. Oecologia (2005) 1.38
The effect of anaesthesia of the airway in dog and man: a study of respiratory reflexes, sensations and lung mechanics. Clin Sci Mol Med (1976) 1.36
Stereopsis and binocular vision after surgery for unilateral infantile cataract. J AAPOS (1999) 1.25
U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett (1994) 1.24
Antischistosomal drugs: past, present ... and future? Pharmacol Ther (1995) 1.20
Woody plant invasion of grasslands: establishment of honey mesquite (Prosopis glandulosa var.glandulosa) on sites differing in herbaceous biomass and grazing history. Oecologia (2013) 1.20
A new active metabolite of "Miracil D". Nature (1965) 1.15
Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ (1996) 1.13
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci U S A (1996) 1.11
kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc Natl Acad Sci U S A (1996) 1.05
Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity. J Pharmacol Exp Ther (1999) 1.04
Purification of the opiate receptor from rat brain. Proc Natl Acad Sci U S A (1981) 1.04
Drug resistance in schistosomes. Parasitol Today (1993) 1.03
14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity. J Med Chem (1993) 1.03
Voltage-gated potassium channels in human ductus arteriosus. Lancet (2000) 1.00
The non specificity of specific nitric oxide synthase inhibitors. Biochem Biophys Res Commun (1992) 1.00
Schistosomicidal activity of lucanthone hydrochloride, hycanthone and their metabolites in mice and hamsters. J Parasitol (1967) 0.96
Emetic activity of N-substituted norapomorphines. J Med Chem (1975) 0.96
Hycanthone, a new active metabolite of lucanthone. J Med Chem (1967) 0.95
Ring-hydroxylated analogues of lucanthone as antitumor agents. J Med Chem (1982) 0.95
Molecular mechanics modeling of oligonucleotide adducts of the antitumor drug cis-diamminedichloroplatinum(II). Biopolymers (1987) 0.95
Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). Circulation (2000) 0.95
Metabolism of remifentanil during liver transplantation. Br J Anaesth (1998) 0.94
Assignment of the appaloosa coat colour gene (LP) to equine chromosome 1. Anim Genet (2004) 0.92
The chemotherapy of schistosomiasis. Annu Rev Pharmacol Toxicol (1985) 0.92
Naphthoquinone antimalarials. XXIX. 2-hydroxy-3-(omega-cyclohexylalkyl)-1,4-naphthoquinones. J Med Chem (1967) 0.91
Redox control of oxygen sensing in the rabbit ductus arteriosus. J Physiol (2001) 0.89
A comparison of oral and parenteral activity of hycanthone and lucanthone in experimental infections with Schistosoma mansoni. Am J Trop Med Hyg (1967) 0.89
Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography. Proc Natl Acad Sci U S A (1985) 0.88
4-[(Aminoalkyl)amino]-1,2-dimethoxynaphthalenes as antimalarial agents. J Med Chem (1980) 0.86
Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism. J Pharmacol Exp Ther (1995) 0.85
Evidence for the mode of antischistosomal action of hycanthone. Life Sci (1985) 0.85
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates. J Med Chem (1977) 0.85
An analysis of multiple mechanisms of adenosine toxicity in baby hamster kidney cells. J Cell Physiol (1985) 0.84
Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor. Biochem Pharmacol (1997) 0.84
Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules. Mol Biochem Parasitol (1992) 0.83
Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme. Steroids (1983) 0.83
Torsional motion and elasticity of the deoxyribonucleic acid double helix and its nucleosomal complexes. Biochemistry (1982) 0.83
Craniofacial electromyogram activation response: another indicator of anesthetic depth. J Clin Monit Comput (1998) 0.81
Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol (2001) 0.81
Binding of oxamniquine to the DNA of schistosomes. Trans R Soc Trop Med Hyg (1990) 0.81
Narcotic antagonists. Fortschr Arzneimittelforsch (1965) 0.81
Identification of kappa opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci U S A (1995) 0.81
Preparation and schistosomicidal activity of some 4-hydroxymethyl-3-chloroanilines. J Med Chem (1967) 0.81
Coronary angioplasty at the time of initial diagnostic coronary angiography in patients with unstable angina. Cathet Cardiovasc Diagn (1988) 0.80
Traumatic aneurysm of a common digital artery--a case report. J Hand Surg Am (1982) 0.78
Analysis of a SNP in exon 7 of equine OCA2 and its exclusion as a cause for appaloosa spotting. Anim Genet (2006) 0.78
Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes. Mol Biochem Parasitol (1988) 0.78
Exercise training improves aerobic capacity and skeletal muscle function in heart transplant recipients. Am J Transplant (2009) 0.78
14 beta-Chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists. Eur J Pharmacol (1997) 0.77
Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent. J Nucl Med (1992) 0.77
Implication of transstenotic coronary pressure gradient measurement during coronary angioplasty. Cathet Cardiovasc Diagn (1986) 0.77
14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone. J Med Chem (1983) 0.77
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists. J Pharmacol Exp Ther (1994) 0.77
Lactic acidosis B associated with solid tumors. Minn Med (1986) 0.77
Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin. J Immunol Methods (1997) 0.77
Recent progress in the chemotherapy of schistosomiasis. Prog Drug Res (1974) 0.77
Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO). J Pharmacol Exp Ther (1992) 0.76
14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes. Biochemistry (1989) 0.76
Historical perspective on the chemistry and development of naltrexone. NIDA Res Monogr (1981) 0.76
Resistance of schistosomes to hycanthone and oxamniquine. Mem Inst Oswaldo Cruz (1989) 0.76
Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin). Invest New Drugs (1987) 0.76
Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO). J Pharmacol Exp Ther (1993) 0.76
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines. J Med Chem (1992) 0.76
Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys. J Pharmacol Exp Ther (1996) 0.76
Napthoquinone antimalarials. XXX. 2-hydroxy-3-[omega-(1-adamantyl)alkyl]-1,4-naphthoquinones. J Med Chem (1967) 0.75
Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochem Pharmacol (1995) 0.75
Speaking out: the views of nurse leaders. NLN Publ (1981) 0.75
Some 14 beta-substituted analogues of N-(cyclopropylmethyl)normorphine. J Med Chem (1981) 0.75
Ego identity status and expressive writing among high school and college students. J Youth Adolesc (1979) 0.75
Recent progress in research on narcotic antagonists. Prog Drug Res (1976) 0.75
N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist. J Pharmacol Exp Ther (1996) 0.75
Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors. Eur J Pharmacol (1995) 0.75
Analogues of hycanthone and lucanthone as antitumor agents. J Med Chem (1983) 0.75
A possible metabolic basis for the schistosomicidal activity of Mirasan and N-(3-chloro-4-methylphenyl)-piperazine. Life Sci (1967) 0.75
An attempt to apply lethal synthesis to the design of chemotherapeutic agents. Fluorinated 5 beta-(hydroxyethyl)-4-methylthiazoles. J Med Chem (1979) 0.75
Nitro and amino derivatives of lucanthone as antitumor agents. J Med Chem (1982) 0.75
Identification of opioid receptors in the immune system using a novel combination of selective opioid ligands and indirect phycoerythrin immunofluorescence. Adv Exp Med Biol (1995) 0.75
Comparison of schistosomicidal activity of xanthenones and 4-methyl-3-chloroanilines and their hydroxymethyl analogs in Swiss mice and Syrian hamsters infected with Schistosoma mansoni. J Med Chem (1969) 0.75
Pharmacology of LAAM. NIDA Res Monogr (1976) 0.75
Synthesis and analgesic activity of some 14 beta-substituted analogues of morphine. J Med Chem (1980) 0.75
The chemistry of LAAM. NIDA Res Monogr (1976) 0.75
Affinity labeling of the mu opioid receptor in bovine striatal membranes with [3H]-14 beta-(bromoacetamido)-7,8-dihydromorphine. Biochemistry (1993) 0.75
Interaction between double stranded poly(dA-dT).poly (dA-dT) and lucanthone. Biochem Biophys Res Commun (1980) 0.75
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist properties. Eur J Pharmacol (1993) 0.75
Nursing and politics go hand in hand. RCN Nurs Stand (1983) 0.75
Affinity labeling and purification of the opiate receptor from rat brain. Adv Biochem Psychopharmacol (1982) 0.75
Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in mice. Eur J Pharmacol (1993) 0.75
Photoaffinity ligands for the mu opioid receptor. Life Sci (1993) 0.75
Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina. J Clin Pharmacol (1995) 0.75
Chronic lung disease and pulmonary hypertension: yes or no to NO? Thorax (1997) 0.75
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates. J Med Chem (1983) 0.75
QSAR: a critical appraisal. NIDA Res Monogr (1978) 0.75
Case 2. Recurrence of myocardial infarction. Can J Cardiol (2000) 0.75
Toxicology of LAAM. NIDA Res Monogr (1976) 0.75
Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther (1994) 0.75
The Queen's Medical Center Honolulu, Hawaii. Nurs Adm Q (1994) 0.75